62
Participants
Start Date
September 2, 2021
Primary Completion Date
March 17, 2023
Study Completion Date
October 12, 2023
TEPEZZA
Intravenous infusion
Placebo
Intravenous infusion
Endocrinology Specialists & Thyroid Center, Greenville
Bascom Palmer Eye Institute / Univ of Miami, Miami
Hamilton Eye Institute / U Tennessee, Memphis
Medical College of Wisconsin, Milwaukee
Mayo Clinic, Rochester
Washington University, St Louis
Neuro-Eye Clinical Trials, Houston
Univ of Colorado Dept of Ophthalmology, Aurora
Las Vegas Endocrinology, Las Vegas
MACRO Trials, Los Angeles
The Private Practice of Raymond Douglas, Beverly Hills
Perlman Medical Offices / UCSD, La Jolla
Lead Sponsor
Amgen
INDUSTRY